FC26: Oral Psoriasis Therapies: A Brighter Horizon: An Online Activity

Oral therapies are providing more ways to harmonize psoriasis treatment goals and patient preferences. Walk through the clinical evidence with expert faculty from the 2026 Fall Clinical Dermatology Conference® and gather insights into guiding your own patients through this broadening therapeutic landscape.
“Sometimes the worst thing we can do for patients is give them too many options because I think it makes the decision very overwhelming. I learned very early on that, rather than listing out all the options, I'll give them buckets. ‘We have topicals, we have phototherapy, we have orals, we have injectables, but I think these are probably the few options that are best for you.’… I think now with some of our oral agents, it truly is a shared experience. I can say, ‘You know, we have good drugs, both oral and injectable. Which one do you think would be best for your lifestyle?’” – Tina Bhutani, MD, MAS
FC26: Oral Psoriasis Therapies: A Brighter Horizon: An Online Activity
This activity is supported by an educational grant from Johnson & Johnson.